Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jennifer Diamond

Concepts (280)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Triple Negative Breast Neoplasms
15
2023
158
6.890
 Why?
Breast Neoplasms
23
2023
1870
4.790
 Why?
Antineoplastic Agents
23
2023
1897
2.760
 Why?
Immunoconjugates
7
2023
87
2.720
 Why?
Antineoplastic Combined Chemotherapy Protocols
19
2023
1361
2.710
 Why?
Pyrimidines
9
2021
378
2.560
 Why?
Receptor, ErbB-2
11
2023
301
2.030
 Why?
Protein Kinase Inhibitors
10
2022
796
1.830
 Why?
Neoplasms
14
2022
2106
1.770
 Why?
Piperazines
4
2020
313
1.760
 Why?
Paclitaxel
6
2022
190
1.680
 Why?
Camptothecin
9
2023
98
1.660
 Why?
Pyrazoles
6
2021
364
1.470
 Why?
Quinoxalines
2
2020
60
1.360
 Why?
Ovarian Neoplasms
4
2020
388
1.340
 Why?
Azepines
3
2020
74
1.300
 Why?
Antibodies, Monoclonal, Humanized
9
2021
666
1.250
 Why?
Cyclin-Dependent Kinase 4
2
2018
33
1.150
 Why?
Cyclin-Dependent Kinase 6
2
2018
37
1.140
 Why?
Histone Deacetylase Inhibitors
3
2023
198
1.050
 Why?
Neutropenia
4
2022
125
0.920
 Why?
Gene Expression Regulation, Neoplastic
5
2020
1148
0.850
 Why?
Xenograft Model Antitumor Assays
11
2021
706
0.810
 Why?
beta Catenin
2
2020
220
0.780
 Why?
Female
48
2023
59581
0.770
 Why?
Breast Neoplasms, Male
2
2018
29
0.760
 Why?
Lymphocytes, Tumor-Infiltrating
2
2020
114
0.730
 Why?
Chemotherapy, Adjuvant
4
2023
333
0.720
 Why?
Receptors, Estrogen
3
2021
372
0.720
 Why?
Cancer Care Facilities
1
2020
31
0.720
 Why?
Maximum Tolerated Dose
9
2022
184
0.710
 Why?
Benzoxazoles
1
2020
16
0.710
 Why?
Carcinoma, Lobular
2
2018
44
0.700
 Why?
eIF-2 Kinase
1
2019
24
0.670
 Why?
Tumor Microenvironment
3
2020
434
0.660
 Why?
Humans
60
2023
114937
0.650
 Why?
Anthracyclines
3
2023
41
0.630
 Why?
Aged
22
2023
19122
0.630
 Why?
Drug Resistance, Neoplasm
4
2020
642
0.620
 Why?
Taxoids
3
2023
94
0.620
 Why?
Wnt Signaling Pathway
1
2019
147
0.600
 Why?
Carcinoma, Ductal, Breast
1
2018
77
0.590
 Why?
Aurora Kinase A
4
2020
52
0.590
 Why?
Trastuzumab
4
2023
89
0.580
 Why?
Pyrazines
2
2018
71
0.570
 Why?
Myocardial Infarction
1
2023
929
0.550
 Why?
Colonic Neoplasms
1
2018
222
0.540
 Why?
Pyridines
2
2018
425
0.530
 Why?
Neoadjuvant Therapy
1
2018
305
0.530
 Why?
Nuclear Proteins
2
2023
593
0.520
 Why?
Angiopoietin-1
1
2015
10
0.500
 Why?
Angiopoietin-2
1
2015
11
0.500
 Why?
Tumor Suppressor Protein p53
3
2016
447
0.480
 Why?
Cell Line, Tumor
9
2022
2725
0.480
 Why?
Medicare
4
2023
666
0.470
 Why?
Middle Aged
23
2021
26806
0.470
 Why?
Colorectal Neoplasms
5
2022
621
0.470
 Why?
Uterine Cervical Neoplasms
1
2017
217
0.460
 Why?
Adult
23
2022
30608
0.430
 Why?
Cell Proliferation
8
2020
2199
0.430
 Why?
Dose-Response Relationship, Drug
6
2022
1856
0.420
 Why?
Treatment Outcome
12
2022
9105
0.420
 Why?
Tumor Suppressor Proteins
1
2015
282
0.420
 Why?
Proto-Oncogene Proteins c-met
1
2013
69
0.420
 Why?
Antineoplastic Agents, Immunological
3
2019
152
0.410
 Why?
Recombinant Fusion Proteins
1
2015
617
0.410
 Why?
Point Mutation
1
2013
217
0.400
 Why?
Triazoles
1
2013
130
0.400
 Why?
Mitochondria
1
2017
751
0.380
 Why?
Angiogenesis Inhibitors
3
2018
215
0.380
 Why?
Mice, Nude
6
2020
635
0.370
 Why?
Carcinoma, Renal Cell
1
2013
173
0.370
 Why?
Neoplasm Recurrence, Local
4
2021
863
0.370
 Why?
Heart Failure
1
2023
1952
0.370
 Why?
Histones
3
2023
536
0.360
 Why?
Clinical Trials, Phase I as Topic
2
2020
46
0.360
 Why?
Neoplasm Metastasis
4
2020
530
0.360
 Why?
Biomarkers, Tumor
2
2014
1054
0.350
 Why?
Aged, 80 and over
8
2020
6364
0.340
 Why?
Genes, BRCA2
1
2009
24
0.340
 Why?
Genes, BRCA1
1
2009
31
0.340
 Why?
Molecular Targeted Therapy
3
2019
347
0.340
 Why?
BRCA2 Protein
1
2009
41
0.330
 Why?
Neoplasm Staging
5
2021
1180
0.330
 Why?
Kidney Neoplasms
1
2013
334
0.320
 Why?
Pregnancy Complications, Neoplastic
1
2009
51
0.320
 Why?
Thrombophilia
1
2009
66
0.320
 Why?
Quinolines
2
2021
129
0.320
 Why?
Aromatase Inhibitors
2
2018
49
0.310
 Why?
DNA-Binding Proteins
1
2015
1317
0.300
 Why?
Receptors, Progesterone
2
2021
319
0.300
 Why?
Antibodies, Monoclonal
3
2020
1270
0.290
 Why?
Mice
9
2021
14936
0.290
 Why?
Apoptosis
6
2022
2371
0.280
 Why?
Models, Biological
1
2014
1630
0.280
 Why?
Liver Neoplasms
1
2009
509
0.250
 Why?
Disease Models, Animal
3
2021
3549
0.230
 Why?
United States
5
2023
12211
0.230
 Why?
Lung Neoplasms
1
2017
2223
0.230
 Why?
Cyclophosphamide
2
2018
217
0.230
 Why?
Radiosurgery
2
2019
303
0.230
 Why?
Animals
11
2021
31839
0.220
 Why?
Doxorubicin
2
2018
286
0.220
 Why?
Disease Progression
4
2019
2392
0.210
 Why?
Biopsy
2
2018
1045
0.200
 Why?
Cyclin-Dependent Kinase 9
1
2022
9
0.200
 Why?
Histone Deacetylase 1
1
2022
16
0.200
 Why?
Administration, Oral
3
2022
731
0.200
 Why?
Aurora Kinases
2
2012
28
0.200
 Why?
Fluorouracil
1
2022
152
0.200
 Why?
G2 Phase Cell Cycle Checkpoints
3
2022
41
0.200
 Why?
Topoisomerase I Inhibitors
2
2022
15
0.200
 Why?
Arrhythmias, Cardiac
1
2023
279
0.190
 Why?
Acetylation
1
2022
211
0.190
 Why?
Male
13
2021
55663
0.190
 Why?
Biliary Tract Neoplasms
1
2021
20
0.190
 Why?
Immunotherapy
2
2023
475
0.180
 Why?
Androstadienes
1
2021
97
0.180
 Why?
Necrosis
2
2019
210
0.180
 Why?
Diarrhea
2
2019
173
0.180
 Why?
Fatigue
2
2022
296
0.180
 Why?
Heterografts
1
2021
117
0.180
 Why?
Carboplatin
1
2021
135
0.180
 Why?
Drug Administration Schedule
3
2017
718
0.180
 Why?
Hospitals, University
1
2021
171
0.180
 Why?
Clinical Trials as Topic
3
2016
934
0.180
 Why?
Histone Deacetylases
1
2022
196
0.180
 Why?
Benzodiazepines
1
2021
116
0.170
 Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
55
0.170
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
96
0.170
 Why?
Immune System
1
2021
173
0.170
 Why?
Myeloid Cell Leukemia Sequence 1 Protein
1
2019
22
0.170
 Why?
Kaplan-Meier Estimate
1
2021
817
0.160
 Why?
Tumor Cells, Cultured
1
2020
855
0.160
 Why?
Aquaporin 4
1
2019
87
0.160
 Why?
Albumins
1
2019
89
0.160
 Why?
Maintenance Chemotherapy
1
2018
22
0.160
 Why?
Antibodies, Bispecific
1
2018
32
0.150
 Why?
Vascular Endothelial Growth Factor A
2
2018
499
0.150
 Why?
Aminopyridines
1
2018
81
0.150
 Why?
Nausea
1
2018
104
0.150
 Why?
Mice, Inbred BALB C
1
2020
1153
0.150
 Why?
Mastectomy
1
2018
99
0.150
 Why?
Breast
1
2018
141
0.150
 Why?
Drug Therapy, Combination
1
2020
954
0.150
 Why?
Radiotherapy, Adjuvant
1
2018
182
0.150
 Why?
Benzimidazoles
1
2018
138
0.150
 Why?
Purines
1
2018
159
0.150
 Why?
Imidazoles
1
2018
211
0.140
 Why?
Topotecan
1
2017
10
0.140
 Why?
Isoflavones
1
2017
16
0.140
 Why?
Nanoparticles
1
2021
313
0.140
 Why?
Calcium-Binding Proteins
1
2018
207
0.140
 Why?
Survival Analysis
1
2020
1220
0.140
 Why?
Programmed Cell Death 1 Receptor
1
2019
195
0.140
 Why?
Hypertension
2
2018
1059
0.140
 Why?
Carbolines
1
2017
27
0.140
 Why?
Heterocyclic Compounds, 4 or More Rings
1
2017
16
0.140
 Why?
Inhibitory Concentration 50
2
2016
75
0.140
 Why?
Neoplasms, Radiation-Induced
1
2016
66
0.140
 Why?
Insulin-Like Growth Factor I
1
2018
286
0.130
 Why?
Cell Survival
1
2019
1022
0.130
 Why?
GPI-Linked Proteins
1
2016
54
0.130
 Why?
Adaptor Proteins, Signal Transducing
1
2018
369
0.130
 Why?
Retrospective Studies
3
2021
12544
0.130
 Why?
Neoplasms, Second Primary
1
2016
94
0.130
 Why?
Tumor Protein p73
1
2015
14
0.120
 Why?
Antibodies, Neoplasm
1
2015
30
0.120
 Why?
Phosphorylation
1
2019
1572
0.120
 Why?
Hodgkin Disease
1
2016
120
0.120
 Why?
Risk Reduction Behavior
1
2016
200
0.120
 Why?
Maytansine
1
2014
13
0.120
 Why?
Demography
1
2015
262
0.120
 Why?
Survival Rate
2
2019
1644
0.120
 Why?
Randomized Controlled Trials as Topic
1
2019
1215
0.120
 Why?
Brain Edema
1
2014
60
0.110
 Why?
Drug Interactions
1
2015
347
0.110
 Why?
Protein Kinases
1
2015
307
0.110
 Why?
Analgesics, Opioid
1
2021
773
0.110
 Why?
Sulfones
1
2014
97
0.110
 Why?
Threonine
1
2013
40
0.110
 Why?
Glycine
1
2014
152
0.110
 Why?
Time Factors
2
2020
6125
0.110
 Why?
Drug Evaluation, Preclinical
1
2013
165
0.110
 Why?
Tumor Stem Cell Assay
1
2012
33
0.110
 Why?
Drug Design
1
2013
151
0.100
 Why?
Methionine
1
2013
144
0.100
 Why?
Heterozygote
1
2013
251
0.100
 Why?
Disease-Free Survival
1
2014
623
0.100
 Why?
Treatment Failure
1
2013
332
0.100
 Why?
In Situ Hybridization, Fluorescence
1
2013
314
0.100
 Why?
Computational Biology
1
2015
531
0.100
 Why?
Neovascularization, Pathologic
1
2013
283
0.100
 Why?
Risk Assessment
1
2020
2975
0.100
 Why?
Cellular Senescence
1
2012
153
0.090
 Why?
Cell Transformation, Neoplastic
1
2013
312
0.090
 Why?
Cluster Analysis
1
2012
460
0.090
 Why?
Carcinoma in Situ
1
2011
44
0.090
 Why?
Receptor Protein-Tyrosine Kinases
1
2013
227
0.090
 Why?
Colorado
1
2020
4091
0.090
 Why?
Mutation
2
2012
3354
0.090
 Why?
Brain Neoplasms
2
2019
987
0.090
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2010
86
0.090
 Why?
Sequence Analysis, DNA
1
2013
729
0.090
 Why?
Tumor Burden
1
2010
262
0.090
 Why?
Pregnancy Trimester, Second
1
2009
66
0.080
 Why?
Keratinocytes
1
2010
216
0.080
 Why?
Mastectomy, Segmental
1
2009
76
0.080
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2009
67
0.080
 Why?
Pregnancy Trimester, First
1
2009
126
0.080
 Why?
Apoptosis Regulatory Proteins
1
2009
171
0.080
 Why?
Lymph Node Excision
1
2009
142
0.080
 Why?
Risk Factors
1
2020
8637
0.070
 Why?
Prognosis
2
2018
3344
0.070
 Why?
Cell Adhesion Molecules
2
2019
168
0.070
 Why?
Risk
1
2009
815
0.070
 Why?
Infusions, Intravenous
2
2019
372
0.070
 Why?
Antigens, Neoplasm
2
2019
222
0.070
 Why?
CD8-Positive T-Lymphocytes
2
2023
692
0.070
 Why?
Gene Expression Profiling
1
2012
1523
0.070
 Why?
Cell Cycle Proteins
2
2023
552
0.060
 Why?
Cell Cycle
2
2018
544
0.060
 Why?
Combined Modality Therapy
2
2019
1126
0.060
 Why?
Signal Transduction
2
2014
4525
0.050
 Why?
Mesylates
1
2022
8
0.050
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
63
0.050
 Why?
Clinical Protocols
1
2023
232
0.050
 Why?
Liver
1
2009
1634
0.050
 Why?
Chimerism
1
2021
28
0.050
 Why?
Lymphoid Tissue
1
2021
62
0.050
 Why?
Lymphocyte Subsets
1
2021
79
0.050
 Why?
Mice, SCID
1
2021
320
0.040
 Why?
SEER Program
1
2021
196
0.040
 Why?
Hormones
1
2020
133
0.040
 Why?
Mice, Inbred NOD
1
2021
561
0.040
 Why?
Infant, Newborn
1
2009
5035
0.040
 Why?
M Phase Cell Cycle Checkpoints
1
2018
23
0.040
 Why?
Tissue Distribution
1
2018
285
0.040
 Why?
Pregnancy
1
2009
5527
0.040
 Why?
Anemia
1
2019
144
0.040
 Why?
Cetuximab
1
2016
91
0.030
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
107
0.030
 Why?
Retreatment
1
2016
67
0.030
 Why?
Neoplasm Transplantation
1
2016
232
0.030
 Why?
Platinum
1
2016
38
0.030
 Why?
Drug Screening Assays, Antitumor
1
2016
180
0.030
 Why?
Hematopoietic Stem Cell Transplantation
1
2021
525
0.030
 Why?
Transcription Factors
1
2023
1530
0.030
 Why?
Proto-Oncogene Proteins p21(ras)
1
2016
229
0.030
 Why?
Biomarkers
2
2016
3418
0.030
 Why?
History, Ancient
1
2015
48
0.030
 Why?
Mice, Knockout
1
2021
2587
0.030
 Why?
Databases, Genetic
1
2015
206
0.030
 Why?
DNA Damage
1
2017
357
0.030
 Why?
Opioid-Related Disorders
1
2021
413
0.030
 Why?
Phenotype
1
2021
2817
0.030
 Why?
Drug Combinations
1
2013
286
0.030
 Why?
Intracellular Signaling Peptides and Proteins
1
2015
386
0.030
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
243
0.030
 Why?
Immunohistochemistry
1
2016
1635
0.020
 Why?
Cohort Studies
1
2021
4903
0.020
 Why?
Transcription, Genetic
1
2017
1317
0.020
 Why?
Biopsy, Needle
1
2011
183
0.020
 Why?
Enzyme Inhibitors
1
2014
752
0.020
 Why?
HT29 Cells
1
2010
36
0.020
 Why?
Proto-Oncogene Proteins
1
2014
611
0.020
 Why?
ErbB Receptors
1
2013
561
0.020
 Why?
Protein-Tyrosine Kinases
1
2013
399
0.020
 Why?
Patient Selection
1
2013
642
0.020
 Why?
Ki-67 Antigen
1
2010
106
0.020
 Why?
Follow-Up Studies
1
2018
4427
0.020
 Why?
Capillary Permeability
1
2010
135
0.020
 Why?
Patient Satisfaction
1
2013
583
0.020
 Why?
Membrane Proteins
1
2015
1022
0.020
 Why?
Positron-Emission Tomography
1
2010
265
0.020
 Why?
Algorithms
1
2015
1474
0.020
 Why?
Magnetic Resonance Imaging
1
2019
3053
0.020
 Why?
Tomography, X-Ray Computed
1
2016
2326
0.020
 Why?
Brain
1
2014
2372
0.010
 Why?
Young Adult
1
2014
10478
0.010
 Why?
Diamond's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (280) concept(s)
_
Co-Authors Expand Description
See all (59) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)